Evidence map›Paper›PMID 29396760›Full record

ReviewJournal of cancer survivorship : research and practice2018

Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?

Ekim Ekinci, Salima Nathoo, Thushara Korattyil, Aisha Vadhariya, Hanna A Zaghloul, Polly A Niravath, Susan M Abughosh, Meghana V Trivedi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cancer survivorship : research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Impact of motivational interviewing on psychosocial and symptom outcomes during breast cancer endocrine therapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  8. Interventions to improve oral endocrine therapy adherence in breast cancer patients.Journal of cancer survivorship : research and practice · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ekim EkinciDepartment of Pharmacy, Houston Methodist Hospital, 6565 Fannin Street, DB1-09, Houston, TX, 77030, USA.
Salima NathooDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX, 77204, USA.
Thushara KorattyilDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX, 77204, USA.
Aisha VadhariyaDepartment of Pharmaceutical Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX, 77204, USA.
Hanna A ZaghloulDepartment of Pharmacy, Houston Methodist Hospital, 6565 Fannin Street, DB1-09, Houston, TX, 77030, USA.
Polly A NiravathDepartment of Internal Medicine, Hematology/Oncology Division, Houston Methodist Hospital, 6550 Fannin Street, Houston, TX, 77030, USA.
Susan M AbughoshDepartment of Pharmaceutical Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX, 77204, USA.
Meghana V TrivediDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX, 77204, USA. mtrivedi@uh.edu.
University of Houston · USHouston Methodist · USMethodist Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEndocrine therapy reduces the risk of breast cancer recurrences and mortality in hormone receptor-positive (HR+) breast cancer survivors. However, non-adherence to treatment remains a significant problem. The aim of this study was to review current literature and ongoing trials to identify interventions employed to improve adherence to adjuvant endocrine therapy (AET) in breast cancer survivors.

methodsWe searched PubMed and the National Library of Medicine registry of clinical trials using the terms "breast cancer" and "adherence" or "compliance" and "intervention" and "medication" or "endocrine therapy" or "hormone therapy" to identify published studies as well as ongoing clinical trials.

resultsThree hundred and sixty-three studies were identified; five studies met the inclusion criteria. Most studies enrolled postmenopausal women diagnosed with early stage HR+ breast cancer. Providing educational materials was the most common intervention implemented to improve adherence to one or more aromatase inhibitors. None of the studies found a significant improvement in adherence with the intervention evaluated. Twelve clinical trials investigating various interventions, mostly based on technology, to improve AET adherence were also identified.

conclusionsImproving adherence to AET in HR+ breast cancer survivors is an urgent medical need. While newer clinical trials are overcoming some of the limitations seen with published studies, tailored interventions led by clinicians need further investigation. IMPLICATIONS FOR CANCER SURVIVORS: Our study highlights the unmet clinical need to develop and test feasible interventions to improve AET adherence in HR+ breast cancer survivors to extend their long-term survival.

Indexed as

Drug MonitoringAntineoplastic Agents, HormonalAromatase InhibitorsBreast NeoplasmsCancer SurvivorsChemotherapy, AdjuvantFemaleHumansNeoplasm Recurrence, LocalRegistriesAntineoplastic Agents, HormonalAromatase InhibitorsBreast cancerComplianceEndocrine therapyInterventionMedication adherence

Identifiers

PMID29396760
OpenAlexW2786957577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.